Skip to main content

Table 3 The descriptive analysis as per the diagnosis of patients on clozapine

From: Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India

Characteristic TRS TRSAD TRBD TD Schizophrenia with suicidality Neuroacanthocytosis Parkinsons with PF PD
Age
 20–29 10 0 1 0 5 0 0 0
 30–39 33 5 1 1 0 1 0 1
 40–49 16 0 2 1 0 0 0 0
 More than 49 7 0 1 1 1 0 1 0
Gender
 Male 48 4 5 3 6 1 1 1
 Female 18 1 0 0 0 0 0 0
Dose of clozapine (mgs)
 Median (range) 325 (150–800) 300 (200–600) 500 (400–500) 100 (50–200) 500 (200–800) 100 75 400
Antipsychotics used prior to clozapine
 Haloperidol 52 3 3 3 4 0 0 1
 Chlorpromazine 2 0 0 0 0 0 0 0
 Olanzapine 51 5 2 2 3 1 1 0
 Resperidone 24 2 2 1 5 0 0 0
 Quetiapine 0 2 2 0 0 0 1 0
 Amisulpride 10 0 0 1 0 0 0 0
 Aripiprazole 3 0 0 0 0 0 0 1
 Paliperidone 1 0 0 0 0 0 0 0
  1. TRS Treatment-resistant schizophrenia, TRSAD Treatment resistant schizoaffective disorder, TRBD Treatment-resistant bipolar disorder, TD Tardive dyskinesia, Parkinsons with PF Parkinsons with psychotic features, PD psychotic depression